Showing results (201-210 of 335) with videos related to

Sort By:
Pageof 34
BMC Pulmonary Medicine|December 13, 2022
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trialAnna J Podolanczuk, John S Kim, Christopher B Cooper, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced SolubilityAndrew M Thompson, Patrick D O'Connor, Vanessa Yardley, et al.
Bioorganic & Medicinal Chemistry|February 23, 2019
Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquilineAdrian Blaser, Hamish S Sutherland, Amy S T Tong, et al.
Bioorganic & Medicinal Chemistry|February 27, 2019
3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channelHamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer's diseaseChristopher J Helal, Mark A Sanner, Christopher B Cooper, et al.
Peptides|April 28, 2010
Exploration of structure-activity relationships at the two C-terminal residues of potent 11mer Glucagon-Like Peptide-1 receptor agonist peptides via parallel synthesisTasir S Haque, Rogelio L Martinez, Ving G Lee, et al.
Bioorganic & Medicinal Chemistry|February 28, 2018
Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocyclesHamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2019
Advancing the Therapeutic Potential of Indoleamides for TuberculosisShichun Lun, Rokeya Tasneen, Tridib Chaira, et al.
European Journal of Medicinal Chemistry|December 28, 2021
Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosisHamish S Sutherland, Guo-Liang Lu, Amy S T Tong, et al.
Bioorganic & Medicinal Chemistry|October 2, 2020
Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosisGuo-Liang Lu, Amy S T Tong, Daniel Conole, et al.
Pageof 34